Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS

• URL: http://arxiv.org/abs/2402.08210v1
• Date: Tue, 13 Feb 2024 04:19:06 GMT
• Title: Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS
• Authors: Mohammad Ghazi Vakili, Christoph Gorgulla, AkshatKumar Nigam, Dmitry Bezrukov, Daniel Varoli, Alex Aliper, Daniil Polykovsky, Krishna M. Padmanabha Das, Jamie Snider, Anna Lyakisheva, Ardalan Hosseini Mansob, Zhong Yao, Lela Bitar, Eugene Radchenko, Xiao Ding, Jinxin Liu, Fanye Meng, Feng Ren, Yudong Cao, Igor Stagljar, Al\'an Aspuru-Guzik, Alex Zhavoronkov
• Abstract summary: We introduce a quantum-classical generative model that seamlessly integrates the power of quantum algorithms trained on a 16-qubit IBM quantum computer. Our work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits.
• Score: 10.732020360180773
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engagement with KRAS. ISM061-018-2 was identified as a broad-spectrum KRAS inhibitor, exhibiting a binding affinity to KRAS-G12D at $1.4 \mu M$. Concurrently, ISM061-22 exhibited specific mutant selectivity, displaying heightened activity against KRAS G12R and Q61H mutants. To our knowledge, this work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits, showcasing the practical potential of quantum-assisted drug discovery to produce viable therapeutics. Moreover, our findings reveal that the efficacy of distribution learning correlates with the number of qubits utilized, underlining the scalability potential of quantum computing resources. Overall, we anticipate our results to be a stepping stone towards developing more advanced quantum generative models in drug discovery.

Related papers

• Hybrid quantum cycle generative adversarial network for small molecule generation [0.0]
  This work introduces several new generative adversarial network models based on engineering integration of parametrized quantum circuits into known molecular generative adversarial networks. The introduced machine learning models incorporate a new multi- parameter reward function grounded in reinforcement learning principles.
  arXiv  Detail & Related papers  (2023-12-28T14:10:26Z)
• Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry [8.98977891798507]
  We proposed a hybrid quantum-classical generative adversarial network (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery.
  arXiv  Detail & Related papers  (2022-10-30T11:57:56Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• Hybrid quantum-classical machine learning for generative chemistry and drug design [0.0]
  We build a compact discrete variational autoencoder with a Boltzmann Machine (RBM) of reduced size in its latent layer. We generate 2331 novel chemical structures with medicinal chemistry and synthetic accessibility properties. Results demonstrate the feasibility of using already existing or soon-to-be-available quantum computing devices as testbeds for future drug discovery applications.
  arXiv  Detail & Related papers  (2021-08-26T08:23:32Z)
• Quantum-Classical Hybrid Algorithm for the Simulation of All-Electron Correlation [58.720142291102135]
  We present a novel hybrid-classical algorithm that computes a molecule's all-electron energy and properties on the classical computer. We demonstrate the ability of the quantum-classical hybrid algorithms to achieve chemically relevant results and accuracy on currently available quantum computers.
  arXiv  Detail & Related papers  (2021-06-22T18:00:00Z)
• Counteracting dephasing in Molecular Nanomagnets by optimized qudit encodings [60.1389381016626]
  Molecular Nanomagnets may enable the implementation of qudit-based quantum error-correction codes. A microscopic understanding of the errors corrupting the quantum information encoded in a molecular qudit is essential.
  arXiv  Detail & Related papers  (2021-03-16T19:21:42Z)
• Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions [80.12620331438052]
  deep learning has become an important tool for rapid screening of billions of molecules in silico for potential hits containing desired chemical features. Despite its importance, substantial challenges persist in training these models, such as severe class imbalance, high decision thresholds, and lack of ground truth labels in some datasets. We argue in favor of directly optimizing the receiver operating characteristic (ROC) in such cases, due to its robustness to class imbalance.
  arXiv  Detail & Related papers  (2020-06-25T08:46:37Z)
• Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics [109.70543391923344]
  CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
  arXiv  Detail & Related papers  (2020-05-22T15:57:58Z)
• The Synthesizability of Molecules Proposed by Generative Models [3.032184156362992]
  Discovery of functional molecules is an expensive and time-consuming process. One class of techniques of growing interest for early-stage drug discovery is de novo molecular generation and optimization. These techniques can suggest novel molecular structures intended to maximize a multi-objective function. However, the utility of these approaches is stymied by ignorance of synthesizability.
  arXiv  Detail & Related papers  (2020-02-17T15:41:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.